Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol ENO1 contributors: mct - updated : 06-12-2011
HGNC name enolase 1, (alpha)
HGNC id 3350
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
HOMOLOGY
Homologene
FAMILY
CATEGORY enzyme , structural protein , antigen , tumor suppressor
SUBCELLULAR LOCALIZATION     plasma membrane
    intracellular
intracellular,cytoplasm,cytosolic
intracellular,nucleus
text
  • nuclear form found in almost all the normal tissues while its expression was retained in only 35p100 of the tumors
  • basic FUNCTION
  • glycolysis, energy pathway converting 2 phospho-D-glycerate to phosphoenol-pyruvate tau-crystallin with reduced enolase activity
  • regulating MYC expression
  • has tumour suppressor activity and high level of ENO1 expression has growth inhibitory effects
  • activated NOTCH1 receptor and ENO1 cooperate in controlling MYC expression through binding the YY1 response element of the MYC promoter to regulate tumorigenesis
  • its structure exhibits distinct surface properties, explaining its various activities, including plasmin(ogen) and DNA binding
  • ENO1-mediated promotion of cell transformation and invasion partly via induced CCL20 expression
  • glycolytic enzyme that catalyses the formation of phosphoenolpyruvate in the cell cytoplasm
  • functions in repressing MYC gene expression and the loss of nuclear ENO1 expression in a large number of invasive ductal breast carcinoma may be a critical step in the development and progression of breast cancer
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • TRAPPC2 interaction with the transcription factors ENO1, PITX1 and SF1
  • binds to the P2 c-myc promoter and competes with TATA-box binding protein (TBP) to suppress gene transcription
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    overexpressed in lymphocytic hypophysitis and other autoimmune disease, and in gastric cancer
    tumoral     --over  
    prognostic role of ENO1 overexpression in head and neck cancer
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
  • nuclear ENO1 appears to be a novel and valuable histochemical marker with potential prognostic value in breast cancer
  • Therapy target
    SystemTypeDisorderPubmed
    cancerdigestivestomach
    MBP-1-suppressed COX2 expression plays an important role in the inhibition of growth and progression of gastric cancer
    ANIMAL & CELL MODELS